Home page    in 
   BioClub members log in here   password:    Click here to view your shopping basket  £0.00 click here to view your shopping basket Your Basket
BioGene
Seegene™
Seegene Technology

Principle - ACP™-PCR

The ACP™ system requires a two-stage PCR (ACP™-based PCR) amplification to maximise the functions of each portion as follows :

(1) 1st stage PCR for generating a specific PCR product
The regulator is not favourable in annealing to the template under the conditions that the 3'-end core portion anneals to a site of the template at a first annealing temperature, such that the regulator is capable of interrupting the annealing of the 5'-end portion and restricting a primer annealing portion to the 3'-end portion. The strength in which the specific annealing of the 3'-end portion sequence occurs is relatively stronger than the strength in which the non-specific annealing occurs under the first annealing temperature, which results in the improvement of primer annealing specificity. In this regard, the effect or performance of the regulator on the 5' and 3'-end portions of ACP is one of the key features of ACP™ Technology.

(2) 2nd stage PCR for amplifying 1st PCR product
Only the resultant product generated from annealing and extension of the 3'-end portion sequence of ACP in step (1) can be amplified close to the theoretical optimum of a two-fold increase of product for each PCR cycle by priming the ACPs at 3'- and 5'- ends under high stringency conditions in which the sequence of the 3'-end core portion alone is not allowed to anneal to the template. In this step, only the sequences at the 3'- and 5'-ends of the 1st PCR product act as donors of priming sequences for the amplification, which results in the amplification of only a target product as a results; this is another key feature of ACP™ Technology.

The effect of ACP is clearly proven by comparison with other conventional short and longer primers for the purpose of the amplification of a target sequence. The ACPs having a 10 target nucleotide sequence (10-mer) at their 3'-end core portions produced an expected target product, whereas the conventional short primers produced no products and the conventional longer primers generated many other non-specific products as well as a target product. Although the tailing of the conventional longer primers were replaced with other universal sequences, non-specific products were generated in a different pattern. This clearly shows that the ACPs are exclusively involved in specific primer annealing, resulting in only a target product in such way PCR specificity is maximised.

Advantages

The advantages to be obtained from the use of ACP™ system in PCR amplification are as follows.

  1. The regulator bridging the 3'- and 5'-end portions restricts a primer annealing portion to the 3'-end core portion during the 1st stage PCR, so that the annealing sequence of a primer can be precisely controlled, when make it possible to design a primer with a desired number of annealing sequence. It is particularly useful when an annealing portion of a primer has to be limited (e.g., single nucleotide polymorphism (SNP) genotyping, DNA microarray screening, and detection of differentially expressed genes).
  2. The regulator bridging the 3'- and 5'-end portions interrupts the annealing of the 5-end portion to the template, and eventually the 5'-end portion not involved in the annealing provides the 3'-end portion with primer annealing specificity.
  3. The specificity of primer annealing is highly sensitive enough to detect even a single base mismatching. It is particularly useful for the identification of a nucleotide variation in a target nucleic acid including, single nucleotide polymorphisms and point mutations.
  4. Non-specific annealing is excluded from the amplification of the 1st primed PCR product by using only the sequences at the 3'- and 5'-ends of the 1st PCR product as donors of priming sequences.
  5. The ACP™ system utilises a two stage PCR (ACP™-based PCR) which allow the products to be excluded from non-specific amplifications.

 

back to top

 

Contact Us Privacy Policy Statement Terms and Conditions ISO 9001
please report problems to webmaster@biogene.com Bookmark and Share